TABLE 26Summary of the monitoring attributes and levels

Attribute included in the DCEValue for each level included in the DCENo monitoring alternative
Risk of developing glaucoma
Number of people out of 10,000 developing glaucoma in 10 years740; 960; 1190; 14101600
Risk of developing severe glaucoma
Number of people out of 10,000 developing severe glaucoma in 10 years25; 60; 100; 130180
Risk of developing visual impairment
Number of people out of 10,000 developing visual impairment in 10 years2; 6; 10; 1525
Unwanted effects of treatmentNone – means that you have not noticed any discomfort or difficulties

Some – means that you have noticed occasional discomfort or difficulty

Quite a lot – means that you are aware of these discomforts or difficulties most of the time

Severe – means that you need or think you need additional treatment to control one or more of these difficulties
None
Communication and understanding of information provided by the health professionalMade me feel at ease and made sure I understood the purpose of monitoring
Made me feel at ease but did not make sure I understood the purpose of monitoring
Did not make me feel at ease but made sure I understood the purpose of monitoring
Did not make me feel at ease and did not make sure I understood the purpose of monitoring
Not applicable
LocationHospital eye clinic

Local optician
No testing
Cost per year (£)15; 30; 50; 70No cost

From: 7, Eliciting preferences for alternative monitoring services using a discrete choice experiment

Cover of Surveillance for Ocular Hypertension: An Evidence Synthesis and Economic Evaluation
Surveillance for Ocular Hypertension: An Evidence Synthesis and Economic Evaluation.
Health Technology Assessment, No. 16.29.
Burr JM, Botello-Pinzon P, Takwoingi Y, et al.
Southampton (UK): NIHR Journals Library; 2012 Jun.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.